Icon

AKEEGA (NDA216793)- (500MG;EQ 50MG BASE,500MG;EQ 100MG BASE)

ABIRATERONE ACETATE; NIRAPARIB TOSYLATE JANSSEN BIOTECH
500MG;EQ 50MG BASE,500MG;EQ 100MG BASE
No No
2038-Mar-27 Expired
None 2026-Aug-11
None No
AKEEGA is a combination of niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, and abiraterone acetate, a CYP17 inhibitor indicated with prednisone for the treatment of adult patients with deleterious or suspected deleterious BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC).
0 0 0
Total Other Developers 2
Drugs with Suitability No
500MG;EQ 50MG BASE ** ** - - -
500MG;EQ 100MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.